Immediate adverse reactions to intravenous immunoglobulin in primary immune deficiencies: a single center experience.


Nain E., Kıykım A. , Kasap N. A. , Barış S., Özen A., Aydıner E. K.

The Turkish journal of pediatrics, vol.62, pp.379-386, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 62
  • Publication Date: 2020
  • Doi Number: 10.24953/turkjped.2020.03.004
  • Title of Journal : The Turkish journal of pediatrics
  • Page Numbers: pp.379-386
  • Keywords: IVIG, adverse reaction, primary immunodeficiencies, COMMON VARIABLE IMMUNODEFICIENCY, REPLACEMENT THERAPY, HUMORAL IMMUNODEFICIENCY, FOLLOW-UP, EFFICACY, CHILDREN, IVIG, CLASSIFICATION, PREVENTION, 5-PERCENT

Abstract

Background and objective. Adverse reactions related to intravenous immunoglobulin (IVIG) infusions vary from 1 to 81%, with an average of 20%. They may be classified as immediate; occurring during the infusion itself or delayed; occurring after the infusion has been ceased. In the present study, we aimed to evaluate the frequency of immediate adverse reactions due to IVIG infusions in primary immune deficiency (PID) patients.